Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Watson Pharmaceuticals receives FDA complete response letter for vaginal gel

Feb. 28, 2012

Esmya approved in Europe

Feb. 27, 2012

Angiochem and GSK launch new collaboration

Feb. 27, 2012

Sirona Biochem assesses lead product in model of diabetes

Feb. 27, 2012

New 11-beta-HSD1 inhibitors developed at High Point Pharmaceuticals

Feb. 27, 2012

SK Biopharmaceuticals begin U.S. phase II trial of SKL-11197

Feb. 24, 2012

FDA advisory committee recommends approval of obesity therapy

Feb. 23, 2012

NICE confirms guidance on prolonged-release exenatide for type 2 diabetes

Feb. 23, 2012

Novel diacylglycerol O-acyltransferase 1 inhibitors synthesized

Feb. 23, 2012

Critical Pharma and U.K. university team up to develop nasal spray for osteoporosis

Feb. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...